Chimera Laboratories Private Limited - Company Profile

It is a healthcare private limited company based in Chennai, Tamil Nadu, India, established in 2010.
2010 Chennai, Tamil Nadu, India Struck Off
Last Updated:
Access Report
About Chimera Laboratories Private Limited

Chimera Laboratories Private Limited, a struck off private limited company, was established on 28 April 2010 in Chennai, Tamil Nadu, India. Engaging in medical & surgical equipment within the healthcare sector, it holds CIN: U33110TN2010PTC075509. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Parangusan Kalisrinivasarathinam (Director), Santhana Gopala Krishna (Director), Prasanna Valavanur Shekar (Director). It is based at 30/38, Babu Rajendra Prasad I Street, West Mambalam, Chennai, Tamil Nadu, 600033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33110TN2010PTC075509

  • Registration Number

    075509

  • Incorporation Date

    28 April 2010

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 23 Days
Company report

Chimera Laboratories Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Chimera Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Chimera Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Parangusan Kalisrinivasarathinam Director 28 Apr 2010 Current
Santhana Gopala Krishna Director 28 Apr 2010 Current
Prasanna Valavanur Shekar Director 28 Apr 2010 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Chimera Laboratories.

Enhance accessibility to Chimera Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Chimera Laboratories revenue growth over time
Chimera Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Chimera Laboratories?

Unlock access to Chimera Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Chimera Laboratories?

Unlock and access historical data on people associated with Chimera Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Chimera Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chimera Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Chimera Laboratories
Recent Activity within the Organization
  • Director Appointment

    Progress on Parangusan Kalisrinivasarathinam was appointed as a Director was appointed as a Director on 28 Apr 2010 & has been associated with this company since 16 years 23 days . was documented.

  • Director Appointment

    The activity Santhana Gopala Krishna was appointed as a Director was appointed as a Director on 28 Apr 2010 & has been associated with this company since 16 years 23 days . was completed.

  • Director Appointment

    The activity Prasanna Valavanur Shekar was appointed as a Director was appointed as a Director on 28 Apr 2010 & has been associated with this company since 16 years 23 days . was completed.

  • Company Incorporation

    Progress on Chimera Laboratories Private Limited was registered on 28 Apr 2010 with Roc Chennai & aged 16 years 23 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Chimera Laboratories Private Limited?

The CIN of Chimera Laboratories Private Limited is U33110TN2010PTC075509.

Where is Chimera Laboratories Private Limited headquartered?

Chimera Laboratories Private Limited is headquartered at 30/38, Babu Rajendra Prasad I Street, West Mambalam, Chennai, Tamil Nadu, 600033.

When was Chimera Laboratories Private Limited incorporated?

Chimera Laboratories Private Limited was incorporated on 28 April 2010.

Who are the current directors of Chimera Laboratories Private Limited?

The current directors of Chimera Laboratories Private Limited are

What is the primary industry of Chimera Laboratories Private Limited?

The primary industry of Chimera Laboratories Private Limited is Healthcare.

Is Chimera Laboratories Private Limited a listed company?

Chimera Laboratories Private Limited is unlisted.

What is the capital structure of Chimera Laboratories Private Limited?

The authorized capital of Chimera Laboratories Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available